Kistler-Tiffany Companies’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$113K Hold
1,200
0.02% 379
2023
Q1
$99.3K Hold
1,200
0.02% 348
2022
Q4
$89.5K Hold
1,200
0.02% 353
2022
Q3
$99K Hold
1,200
0.02% 283
2022
Q2
$114K Hold
1,200
0.02% 271
2022
Q1
$141K Hold
1,200
0.03% 253
2021
Q4
$155K Hold
1,200
0.03% 222
2021
Q3
$136K Hold
1,200
0.03% 229
2021
Q2
$124K Hold
1,200
0.03% 242
2021
Q1
$100K Hold
1,200
0.03% 248
2020
Q4
$109K Hold
1,200
0.03% 217
2020
Q3
$96K Hold
1,200
0.03% 215
2020
Q2
$83K Hold
1,200
0.03% 218
2020
Q1
$93K Hold
1,200
0.03% 197
2019
Q4
$93K Hold
1,200
0.03% 201
2019
Q3
$88K Hold
1,200
0.03% 205
2019
Q2
$74K Hold
1,200
0.03% 222
2019
Q1
$77K Buy
1,200
+1,035
+627% +$59.1K 0.03% 209
2018
Q4
$8K Hold
165
﹤0.01% 428
2018
Q3
$10K Sell
165
-168
-50% -$8.22K ﹤0.01% 424
2018
Q2
$16K Sell
333
-867
-72% -$40.5K 0.01% 368
2018
Q1
$56K Hold
1,200
0.02% 255
2017
Q4
$45K Hold
1,200
0.02% 296
2017
Q3
$44K Hold
1,200
0.02% 289
2017
Q2
$47K Hold
1,200
0.02% 264
2017
Q1
$38K Hold
1,200
0.02% 275
2016
Q4
$37K Hold
1,200
0.02% 279
2016
Q3
$48K Hold
1,200
0.02% 258
2016
Q2
$40K Buy
+1,200
New +$41.1K 0.02% 275

Other funds holding EW

Kistler-Tiffany Companies's EW Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Edwards Lifesciences (EW) position steady in Q2 2023 at 1,200 shares worth $113K. The position accounts for 0.02% of the portfolio, ranked #379.

Kistler-Tiffany Companies first reported a position in EW in Q2 2016 and has held it in 29 quarters since. The position peaked at $155K in Q4 2021. 1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

  • Kistler-Tiffany Companies held 1,200 shares of Edwards Lifesciences worth $113K as of Q2 2023.
  • Kistler-Tiffany Companies left its Edwards Lifesciences share count unchanged in Q2 2023.
  • Edwards Lifesciences made up 0.02% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #379 holding.
  • Kistler-Tiffany Companies first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 29 quarters since.
  • Kistler-Tiffany Companies's Edwards Lifesciences position peaked at $155K in Q4 2021.
  • 1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.